Cargando…

Correction: Moeker, N.; et al. Antibody Selection for Cancer Target Validation of FSH-Receptor in Immunohistochemical Settings. Antibodies 2017, 6, 15

Detalles Bibliográficos
Autores principales:	Möker, Nina, Peters, Solveig, Rauchenberger, Robert, Ghinea, Nicolae, Kunz, Christian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2018
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6640680/ http://dx.doi.org/10.3390/antib7030031

Ejemplares similares

Antibody Selection for Cancer Target Validation of FSH-Receptor in Immunohistochemical Settings
por: Möker, Nina, et al.
Publicado: (2017)

Antibodies to watch in 2017
por: Reichert, Janice M.
Publicado: (2016)

Reply to comments by Olson et al. 2017 and Stien 2017
por: Chapron, Guillaume, et al.
Publicado: (2017)

A comment on Mokabel et al. (2017)
por: Basu, Saurav
Publicado: (2018)

Comment on the publication of Amiryousefi et al. (2017)
por: Virág, Eszter, et al.
Publicado: (2017)

Anti-Angiogenic Therapy: Albumin-Binding Proteins Could Mediate Mechanisms Underlying the Accumulation of Small Molecule Receptor Tyrosine Kinase Inhibitors in Normal Tissues with Potential Harmful Effects on Health
por: Ghinea, Nicolae
Publicado: (2021)

FSH regulates acetycholine production by ovarian granulosa cells
por: Mayerhofer, Artur, et al.
Publicado: (2006)

Reply to Brandt et al., “Antibodies to Nucleocapsid Are Not Diagnostic for Long COVID”
por: Fogh, Kamille, et al.
Publicado: (2023)

Acknowledgement to Reviewers of Antibodies in 2017
Publicado: (2018)

Development and biophysical characterization of a humanized FSH–blocking monoclonal antibody therapeutic formulated at an ultra-high concentration
por: Rojekar, Satish, et al.
Publicado: (2023)

Development and Biophysical Characterization of a Humanized FSH–Blocking Monoclonal Antibody Therapeutic Formulated at an Ultra–High Concentration
por: Rojekar, Satish, et al.
Publicado: (2023)

FSH Beyond Fertility
por: Lizneva, Daria, et al.
Publicado: (2019)

Difficulties in Generating Specific Antibodies for Immunohistochemical Detection of Nitrosylated Tubulins
por: Kamnev, Anton, et al.
Publicado: (2013)

Drug-resistant tuberculosis: Response to More et al. (2017)
por: Basu, Saurav
Publicado: (2017)

Larregue’s Critique of Cofnas et al. (2017): A Rejoinder
por: Cofnas, Nathan, et al.
Publicado: (2018)

Effects of Extra-Long-Acting Recombinant Bovine FSH (bscrFSH) on Cattle Superovulation
por: Gutiérrez-Reinoso, Miguel A., et al.
Publicado: (2022)

Electroconvulsive Therapy and Oxidative Stress: Comment on the Article of Şenyurt et al. (Clin Psychophacol Neurosci 2017;15:40–46)
por: Kalelioglu, Tevfik, et al.
Publicado: (2017)

Reply to Nie et al. and Bhammar et al.
por: Peters, Michael C., et al.
Publicado: (2022)

SAT669 Development And Biophysical Characterization Of A Humanized FSH-blocking Monoclonal Antibody Therapeutic Formulated At An Ultra-high Concentration
por: Rojekar, Satish, et al.
Publicado: (2023)

Correction: Mehrling, T.; et al. Challenges in Optimising the Successful Construction of Antibody Drug Conjugates in Cancer Therapy. Antibodies 2018, 7, 11
por: Mehrling, Thomas, et al.
Publicado: (2018)

Immunohistochemical techniques in the early screening of monoclonal antibodies to human colonic epithelium
por: Finan, P. J., et al.
Publicado: (1982)

In vitro immunohistochemical localization of S-phase cells by a monoclonal antibody to bromodeoxyuridine.
por: Lee, S. S., et al.
Publicado: (1989)

PMab-219: A monoclonal antibody for the immunohistochemical analysis of horse podoplanin
por: Furusawa, Yoshikazu, et al.
Publicado: (2019)

Can FSH influence longevity?
por: Bartke, Andrzej
Publicado: (2017)

Pharmacogenetics of FSH Action in the Male
por: Schubert, Maria, et al.
Publicado: (2019)

Pharmacogenetics of FSH Action in the Female
por: Conforti, Alessandro, et al.
Publicado: (2019)

Molecular Mechanisms of Action of FSH
por: Casarini, Livio, et al.
Publicado: (2019)

FSH for the Treatment of Male Infertility
por: Casarini, Livio, et al.
Publicado: (2020)

FSH-blocking therapeutic for osteoporosis
por: Gera, Sakshi, et al.
Publicado: (2022)

In Vitro Impact of FSH Glycosylation Variants on FSH Receptor-stimulated Signal Transduction and Functional Selectivity
por: Zariñán, Teresa, et al.
Publicado: (2020)

Commentary: FSH and various forms of FSH receptors: distribution and their functions in gonads and extra-gonadal tissues
por: Kakar, Sham S., et al.
Publicado: (2021)

Response to Comments by Vuksan V. et al., Nutrients 2017, 9, 398, Regarding an Article by Solah V.A. et al., Nutrients 2017, 9, 149
por: Solah, Vicky A., et al.
Publicado: (2017)

Development of an Immunohistochemical Assay for Siglec-15
por: Shafi, Saba, et al.
Publicado: (2022)

Addendum: Hoffmann, C.; et al. Autoantibodies in Neuropsychiatric Disorders. Antibodies 2016, 5, 9
por: Hoffmann, Carolin, et al.
Publicado: (2018)

Differential Regulation of Human and Mouse Myometrial Contractile Activity by FSH as a Function of FSH Receptor Density
por: Stilley, Julie A.W., et al.
Publicado: (2016)

SAT-295 Low Dose rFSH Prior to HCG-rFSH Therapy in Kallmann Syndrome
por: Yoshizawa-Ogasawara, Atsuko, et al.
Publicado: (2019)

Predictive value of age-specific FSH levels for IVF-ET outcome in women with normal ovarian function
por: Fang, Tingfeng, et al.
Publicado: (2015)

Progesterone receptor in the chick oviduct: an immunohistochemical study with antibodies to distinct receptor components
Publicado: (1984)

Immunohistochemical Examination of Novel Rat Monoclonal Antibodies against Mouse and Human Podoplanin
por: Kaji, Chiaki, et al.
Publicado: (2012)

Pepsinogens I and II in Gastric Cancer: An Immunohistochemical Study Using Monoclonal Antibodies
por: Huang, Shih Che, et al.
Publicado: (1988)

Cannot write session to /tmp/vufind_sessions/sess_ma4mfpr3ad06v0g8vshe08losu